- Home
- VIRT vs CNTA Comparison
VIRT vs CNTA Comparison
Compare VIRT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- CNTA
- Stock Information
- Founded
- VIRT 2008
- CNTA 2020
- Country
- VIRT United States
- CNTA United Kingdom
- Employees
- VIRT N/A
- CNTA N/A
- Industry
- VIRT Investment Bankers/Brokers/Service
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- VIRT Finance
- CNTA Health Care
- Exchange
- VIRT Nasdaq
- CNTA Nasdaq
- Market Cap
- VIRT 2.8B
- CNTA 2.3B
- IPO Year
- VIRT 2015
- CNTA 2021
- Fundamental
- Price
- VIRT $36.15
- CNTA $26.24
- Analyst Decision
- VIRT Hold
- CNTA Strong Buy
- Analyst Count
- VIRT 7
- CNTA 9
- Target Price
- VIRT $41.43
- CNTA $31.63
- AVG Volume (30 Days)
- VIRT 1.0M
- CNTA 1.7M
- Earning Date
- VIRT 10-29-2025
- CNTA 11-05-2025
- Dividend Yield
- VIRT 2.69%
- CNTA N/A
- EPS Growth
- VIRT 132.69
- CNTA N/A
- EPS
- VIRT 4.62
- CNTA N/A
- Revenue
- VIRT $2,694,104,000.00
- CNTA $15,000,000.00
- Revenue This Year
- VIRT N/A
- CNTA N/A
- Revenue Next Year
- VIRT N/A
- CNTA N/A
- P/E Ratio
- VIRT $7.72
- CNTA N/A
- Revenue Growth
- VIRT 41.05
- CNTA 118.88
- 52 Week Low
- VIRT $31.89
- CNTA $9.60
- 52 Week High
- VIRT $45.77
- CNTA $27.18
- Technical
- Relative Strength Index (RSI)
- VIRT 63.50
- CNTA 67.02
- Support Level
- VIRT $34.28
- CNTA $21.14
- Resistance Level
- VIRT $35.43
- CNTA $23.08
- Average True Range (ATR)
- VIRT 0.93
- CNTA 1.94
- MACD
- VIRT 0.32
- CNTA -0.02
- Stochastic Oscillator
- VIRT 94.48
- CNTA 94.18
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.